Benzene

Benzene

SCHEMBL7054638

CC#N.O.c1ccccc1

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Benzene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.35
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL1039544 1.00
Benzene SCHEMBL28159903 1.00 TSHR (0.35) TSHRTP53
Benzene SCHEMBL2174781 1.00 TSHR (0.35) TSHRTP53
Benzene SCHEMBL28315068 0.95 TSHR (0.33) TSHRTP53
Benzene SCHEMBL28307657 0.95 TSHR (0.33) TSHRTP53
Benzene SCHEMBL17111929 0.95 TSHR (0.33) TSHRTP53
Benzene SCHEMBL28208154 0.95 TSHR (0.33) TSHRTP53
Benzene SCHEMBL27912368 0.91 TSHR (0.32) TSHR
Benzene SCHEMBL28322306 0.87 TSHR (0.30) TSHR
Benzene SCHEMBL11789304 0.83 CA1 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110066226-B Refining process of acetonitrile-containing wastewater 北京化工大学 2020-06-30 CN claimed
CN-110066226-A A kind of process for refining containing ethane nitrile wastewater 北京化工大学 2019-07-30 CN claimed
CN-102239444-B Electrochromic optical element having an apodized aperture PPG IND OHIO INC 2014-08-13 CN claimed
CN-102239444-A Electrochromic optical element having an apodized aperture PPG IND OHIO INC 2011-11-09 CN claimed
CN-110066226-B Refining process of acetonitrile-containing wastewater 北京化工大学 2020-06-30 CN disclosed
CN-110066226-B Refining process of acetonitrile-containing wastewater 北京化工大学 2020-06-30 CN disclosed
CN-110066226-A A kind of process for refining containing ethane nitrile wastewater 北京化工大学 2019-07-30 CN disclosed
CN-110066226-A A kind of process for refining containing ethane nitrile wastewater 北京化工大学 2019-07-30 CN disclosed
CN-108586178-A The manufacturing method of nitrile and its corresponding amine 中国石油化工股份有限公司 2018-09-28 CN disclosed
CN-104557610-B Process for the manufacture of nitriles and their corresponding amines 中国石油化工股份有限公司 2018-04-27 CN disclosed
CN-104557610-A Process for the manufacture of nitriles and their corresponding amines CHINA PETROLEUM & CHEMICAL 2015-04-29 CN disclosed
CN-102239444-B Electrochromic optical element having an apodized aperture PPG IND OHIO INC 2014-08-13 CN disclosed
CN-102239444-A Electrochromic optical element having an apodized aperture PPG IND OHIO INC 2011-11-09 CN disclosed
US-6602895-B2 Inhibitors of factor Xa with a neutral P1 specificity group BRISTOL-MYERS SQUIBB COMPANY 2003-08-05 US disclosed
US-20030092740-A1 Inhibitors of factor Xa with a neutral P1 specificity group GALEMMO ROBERT A (US) 2003-05-15 US disclosed
US-6403620-B1 ANTICOAGULANT AGENTS FOR TREATMENT AND PREVENTION OF THROMBOEMBOLIC DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-06-11 US disclosed
US-5998424-A ANTICOAGULANTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-12-07 US disclosed
CN-1119062-A Process for preparing agricultural fungicide myclobutanil JIANGSU INST OF PESTICIDE (CN) 1996-03-27 CN disclosed
US-3959468-A Antibiotic equisetin and method of production THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1976-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092740-A1 Inhibitors of factor Xa with a neutral P1 specificity group F12, F11, SERPINC1 TSHR 1595/4885TP53 4728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.